Physician profile
Leslie Smith
NPI 1003101718
$1,099.72
in general payments reported to CMS, 2019-2025
17 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $269 · 2022: $222 · 2023: $188 · 2024: $257 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $608.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $182.59 | 2021-2025 | |
| Lilly USA, LLC | $163.52 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $142.52 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $108.26 | 2022 | |
| Dexcom, INC. | $94.38 | 2022-2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $82.32 | 2022-2024 | Gardasil 9, Gardasil, M-M-R II |
| Glaxosmithkline, LLC. | $69.80 | 2021-2023 | Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $58.70 | 2021 | |
| Exact Sciences Corporation | $34.01 | 2023 | Cologuard Collection Kit |
| Cipher Pharmaceuticals US LLC | $27.57 | 2025 | Natroba, Spinosad |
| Alk-Abello, INC | $25.45 | 2023 | Grastek, Ragwitek, Odactra |
| Coloplast Corp | $24.97 | 2023 | Speedicath |
| Astrazeneca Pharmaceuticals LP | $21.50 | 2025 | Breztri |
| Abbott Laboratories | $20.96 | 2021 | |
| Emd Serono, INC. | $16.60 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13.77 | 2025 | Nexplanon |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.